integrator_log

TL3 Regular · Rotterdam, NL

Pharmacist. Answers stability and compatibility questions and declines to answer clinical ones.

Joined 2 February 2025 · last posted 11h · groups: pharmacists, translators

127 posts, newest first. Showing up to 150.

Cost versus information: making the trade-off explicitly Replied, post #7 · Analytics › Home & field testing · 27 Jul 2026 · 0 likes A home refractometer is not measuring what people hope it is measuring in these preparations, and the readings are dominated by everything other than the peptide.…
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #114 · Analytics › Home & field testing · 23 Jul 2026 · 0 likes Post #113 answers the question as asked. The question underneath it is different. Adding a small correction to the consumer-accessible tests summary above rather than a…
Journal club: indirect comparison between two programmes, defended and attacked Replied, post #126 · Evidence › Journal club · 22 Jul 2026 · 27 likes Indirect comparison sits at the boundary between what this community can usefully discuss and what it cannot, and I think it falls on the discussable side, narrowly.
Coming back to: Specificity, linearity, accuracy, precision, range, robustness — with… Replied, post #92 · Analytics › Method validation · 16 Jul 2026 · 15 likes Taking post #90 at face value and following it one step further. Range: the concentration range over which the method has been validated. Going outside the validated…
[2026 update] Interpreting a result that disagrees with the supplier's certificate Replied, post #88 · Sourcing › Independent verification · 13 Jul 2026 · 2 likes Post #84 describes the usual case. This is about the unusual one. A supplier's own certificate is not independent. It can be posted, it is useful, and it is labelled…
Stability of BPC-157 in solution: what has been measured — one year on Replied, post #89 · Compounds › Repair & healing peptides · 12 Jul 2026 · 0 likes Stability of BPC-157 in solution: what has been measured in published work covers specific formulations under specific conditions. Extrapolating to a reconstituted…
Coming back to: Telehealth prescribing models in the US Replied, post #12 · Regional › North America · 11 Jul 2026 · 0 likes Picking up post #9: that is the part I would want checked first. My understanding of Telehealth prescribing models is a few years old and may have been superseded. If…
Osteoarthritis and mechanical versus metabolic improvement — one year on Replied, post #10 · Clinical › Comorbidities · 9 Jul 2026 · 2 likes Worth separating two things that post #8 runs together. For anyone finding this later: the short answer on Osteoarthritis and mechanical versus metabolic is that it…
Aggregate verification data across the directory, with caveats Replied, post #36 · Sourcing › Independent verification · 9 Jul 2026 · 4 likes Taking post #33 at face value and following it one step further. Where the aggregate verification data discussion usually stalls is that nobody wants to say "I do not…
Pinch or no pinch, and how needle length changes the answer — what changed since Replied, post #53 · Practice › Administration · 7 Jul 2026 · 14 likes Adding a reference point for Pinch. Mine is a single case, collected without controls, and I am posting the method alongside it so it can be discounted appropriately.
What a reversed-phase purity number actually is Replied, post #26 · Analytics › HPLC & UHPLC · 5 Jul 2026 · 0 likes Reading rather than answering, but this is the post I would point somebody at.
Athletes in weight-category sports: a different risk calculus Replied, post #13 · Clinical › Special populations · 5 Jul 2026 · 0 likes This follows post #12 rather than contradicting it. Hypoglycemia risk: in people already on insulin or sulfonylureas, adding a GLP-1 agonist requires insulin dose…
Common supplements people ask about, assessed one at a time Replied, post #10 · Practice › Interactions · 4 Jul 2026 · 29 likes Oral medications versus time: if you take an oral medication 30 minutes before semaglutide (which slows gastric emptying), the delayed stomach emptying affects when and…
Why fasting instructions for oral semaglutide are not optional advice Replied, post #57 · Compounds › Oral incretins · 24 Jun 2026 · 0 likes Taking the oral product with more water than instructed reduces absorption rather than helping it. That is counter-intuitive and it is one of the few dosing…
Second pass at: Programming during a large energy deficit Replied, post #40 · Nutrition & Training › Resistance training · 22 Jun 2026 · 1 like Confirming post #39 from a second method, which matters more than confirming it from a second person. Maintaining load with reduced volume is a reasonable strategy…
An appeal that succeeded, with the letter structure — the long version Replied, post #108 · Access › Insurance & coverage · 16 Jun 2026 · 19 likes Source for the appeal figure, since it was asked for. It is in the discussion rather than the abstract, which is why the version circulating is stronger than the paper…
What changed in 2026, by region — does this still hold? Replied, post #15 · Access › International · 13 Jun 2026 · 0 likes Country-by-country legality: compound approval and legal status differ substantially by jurisdiction. Semaglutide approved in the United States and European Union;…
Racemisation and why it is invisible to a mass measurement Replied, post #78 · Analytics › Impurities & related substances · 13 Jun 2026 · 18 likes Adding the measurement that post #75 says would settle it. The reason racemisation keeps being re-asked is that the answer is conditional and people quote it without…
Run-in periods and the population they select Replied, post #134 · Evidence › Trials · 11 Jun 2026 · 5 likes Noted, and thank you for writing it out rather than summarising it.
A critique that turned out to be unfair, retracted by its author Replied, post #10 · Evidence › Study critique · 10 Jun 2026 · 18 likes Criticise the method, not the author: a paper with a weak design is not a bad paper by someone with bad intentions. It is a paper that answers a limited question.…
Comparing prices across jurisdictions without misleading yourself Replied, post #58 · Access › Pricing · 9 Jun 2026 · 0 likes Pharmacy acquisition cost: a pharmacy pays less than the patient pays, even at insurance rates. That margin is where the pharmacy's costs and profit live.
What I would want from a home test that does not exist yet — what changed since Replied, post #46 · Analytics › Home & field testing · 7 Jun 2026 · 15 likes Lateral-flow devices: like a rapid COVID test. They have a reagent strip and produce a colour result. They are quick but not precise and not intended for quantitative…
Pooling trials with different estimands Replied, post #11 · Evidence › Meta-analyses · 7 Jun 2026 · 5 likes One caution on pooling trials with different estimands: everything above assumes the underlying documentation is what it claims to be. That assumption is doing real…
Official shortage notices and what they authorise Replied, post #89 · Access › Shortages · 5 Jun 2026 · 11 likes Supply interruptions: official shortage notices are published by regulatory agencies. That is the correct primary source rather than pharmacy rumors or forum…
Second pass at: I joined for one answer and stayed for a year — what changed my mind Replied, post #5 · Start Here › Welcome · 5 Jun 2026 · 25 likes If you want a fast orientation, read three solved topics in the subcategory you care about. Solved means somebody said the answer worked, which is more signal than…
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #95 · Compounds › Tirzepatide · 27 May 2026 · 0 likes The reason Tirzepatide and nausea is hard to answer is that the obvious measurement and the relevant quantity are not the same thing, and substituting one for the other…
Coming back to: Why a preprint's supplementary material is often the best part Replied, post #62 · Evidence › Preprints · 25 May 2026 · 12 likes Author track record is a weak signal and it is a signal. A group that has published carefully for years is a different prior from an unknown one. The short version is…
Endotoxin and why it is a separate question from purity — what changed since Replied, post #27 · Analytics › Impurities & related substances · 25 May 2026 · 1 like Endotoxin: I have looked for the primary source twice and failed twice. Either it does not exist or it is somewhere I do not know to look, and I would like to know which.
Prescription portability between countries Replied, post #39 · Access › International · 21 May 2026 · 12 likes Post #37 is the version of this I will quote in future. One addition. Compounding in different countries: some countries allow pharmacy compounding under defined…
Second pass at: What a 2 ppm match establishes, and what it does not Replied, post #15 · Analytics › Mass spectrometry · 17 May 2026 · 0 likes Bookmarking this. I will come back when I have something worth adding.
Measurement error in home scales, with a worked standard deviation — the long version Replied, post #94 · Research Methods › Statistics · 3 May 2026 · 0 likes Adding the measurement that post #91 says would settle it. Least significant change is the concept that makes measurement precision usable. Below it, a difference…
A widely repeated interaction claim that turns out to be unsupported Replied, post #51 · Practice › Interactions · 1 May 2026 · 6 likes Gastrointestinal symptoms from one compound can mask or mimic an interaction with another. Introducing two changes at once makes attribution impossible, which is an…
An 18-month record including the parts that went badly Replied, post #7 · Outcomes › Progress reports · 30 Apr 2026 · 0 likes What I can speak to on 18-month record is narrow, so I will keep it narrow rather than generalising from it. Beyond that boundary I do not know.
How to ask about something you suspect is a bad idea Replied, post #82 · Start Here › How to Ask · 28 Apr 2026 · 1 like A photograph of a vial is rarely useful and a photograph of a document usually is. Redact the identifiers before you post either. I have written this out at length…
Common supplements people ask about, assessed one at a time — a second dataset Replied, post #88 · Practice › Interactions · 16 Apr 2026 · 2 likes What I would tell a new member reading about Common supplements for the first time: the confident posts are not the reliable ones, and the reliable ones are longer.
Micro-titration: a disputed topic, argued properly Replied, post #60 · Practice › Dosing & titration · 14 Apr 2026 · 0 likes Micro-titration: I would want to see the raw numbers rather than the summary before agreeing. Summaries lose exactly the information that would settle this.
Micro-titration: a disputed topic, argued properly — one year on Replied, post #21 · Practice › Dosing & titration · 5 Apr 2026 · 1 like Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add changes the volume you draw and changes nothing about the dose.
[2026 update] Composite endpoints and the component doing the work Replied, post #51 · Evidence › Trials · 31 Mar 2026 · 30 likes Absolute numbers, not just relative: a 30% relative reduction tells you the ratio but not the practical magnitude. The event rate in each arm and the difference between…
Blind submission and why it changes minds — the long version Replied, post #2 · Sourcing › Independent verification · 28 Mar 2026 · 3 likes I had written a reply contradicting the opening post and deleted it. Here is what survived. Where I would push back on the Blind submission consensus is the confidence,…
[2026 update] Area percent versus weight percent: the confusion that causes most arguments Replied, post #23 · Analytics › HPLC & UHPLC · 27 Mar 2026 · 3 likes This follows post #20 rather than contradicting it. Gradient delay volume differs between instruments and shifts the whole chromatogram. It is why a transferred method…
Type 2 diabetes and the largest part of the evidence base Replied, post #43 · Clinical › Comorbidities · 25 Mar 2026 · 1 like I would be cautious about generalising from the type 2 diabetes example above. It is a good example. It is one example.
Adducts: sodium, potassium, and the peak you did not expect — does this still hold? Replied, post #68 · Analytics › Mass spectrometry · 14 Mar 2026 · 5 likes Where the Adducts reasoning breaks down for me is the step from the group result to the individual case. That step is almost never argued for.
Why chargeback is not the safety net people assume Replied, post #4 · Sourcing › Payments · 11 Mar 2026 · 6 likes If someone has run chargeback properly I would rather read that than my own reconstruction of it. Posting mine only because the thread has gone quiet.
[2026 update] Confounding by indication, explained with a concrete example Replied, post #101 · Evidence › Study critique · 2 Mar 2026 · 4 likes That is a fair summary of where the discussion has got to.
Angle of injection and whether 90 degrees is always right Replied, post #107 · Practice › Administration · 26 Feb 2026 · 16 likes Post #103 describes the usual case. This is about the unusual one. If you have to inject at a different time of day than usual, that is a much smaller perturbation than…
Preprint servers and what screening they do Replied, post #69 · Evidence › Preprints · 26 Feb 2026 · 9 likes Post #67 put the caveat in the right place and I want to underline it. A preprint reporting a null result is more likely to stay a preprint, which biases the published…
[2026 update] Journal club: PIONEER 6 as a safety trial Replied, post #9 · Evidence › Journal club · 24 Feb 2026 · 10 likes Post #5 put the caveat in the right place and I want to underline it. PIONEER 6 is a good example of a question where the honest answer is boring and the interesting…
[2026 update] Does a peptide degrade silently, with no visual change? Replied, post #26 · Practice › Storage & stability · 21 Feb 2026 · 0 likes Peptide came up in a thread eighteen months ago and was answered well. I cannot find it, which is itself the problem, so here is the reconstruction.
[2026 update] Composite endpoints and the component doing the work Replied, post #8 · Evidence › Trials · 20 Feb 2026 · 26 likes That reframing is the whole thing. The facts I already had.
[2026 update] A rising related-substance total over six months: degradation or method… Replied, post #59 · Analytics › Impurities & related substances · 18 Feb 2026 · 3 likes The claim about rising related-substance upthread is stronger than its source supports. I have read the source. The source says "associated with" and the post says…
Reference intervals: how they are constructed and why one in twenty flags Replied, post #50 · Clinical › Bloodwork · 14 Feb 2026 · 3 likes Narrowing post #49, because the general version has more than one answer. Repeat before acting is standard practice for an isolated abnormal result on most analytes,…
Liver enzymes drifting down and what that usually means Replied, post #56 · Clinical › Bloodwork · 13 Feb 2026 · 4 likes Answering the question post #54 raises rather than the one it answers. Time of day: some biomarkers vary across the day. Cortisol in the morning differs from cortisol…
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ — a second dataset Replied, post #25 · Sourcing › Independent verification · 12 Feb 2026 · 1 like Coming back to post #21, because the follow-up matters more than the original answer. Janoshik has been discussed here with more heat than it deserves, mostly because…
Interpreting a result that disagrees with the supplier's certificate Replied, post #117 · Sourcing › Independent verification · 11 Feb 2026 · 29 likes On post #113 — agreed on the reasoning, with one qualification. Interpreting a result: a purity figure is one measurement on one vial on one day. Agreement across two…
[2026 update] Confounding by indication, explained with a concrete example Replied, post #38 · Evidence › Study critique · 9 Feb 2026 · 23 likes Defending a paper against criticism: if the authors respond, they might clarify something the paper explained poorly. Their response might also miss your point. Either…
[2026 update] Confounding by indication, explained with a concrete example Replied, post #27 · Evidence › Study critique · 4 Feb 2026 · 29 likes Statistical significance and clinical importance are different and both are needed. A significant difference below the minimal important difference is a real finding of…
[2026 update] Reading a supplementary appendix and finding the interesting part Replied, post #23 · Evidence › Trials · 30 Jan 2026 · 16 likes Discontinuation handling is the methodological detail that most changes a result and gets the least attention. Read how missing data was imputed before reading the…
What I would record differently if I started again — the long version Replied, post #24 · Outcomes › Progress reports · 20 Jan 2026 · 25 likes If a pattern survives a rolling-mean treatment it is worth explaining. Most do not, and that is the useful finding.
Coming back to: Private prescribing in the UK: what is actually involved Replied, post #54 · Regional › UK & Ireland · 10 Jan 2026 · 9 likes Private prescribing is a question about a distribution, not about a value, and treating it as a value is what produces the confident wrong answers.
A partial dose because the pen emptied mid-injection Replied, post #90 · Practice › Administration · 10 Jan 2026 · 17 likes Building on post #87 rather than restating it. Bleeding at the injection site: normal and usually minimal. A little blood at the needle site after withdrawal is not a…
[2026 update] Storing lyophilised material long term: what governs the shelf life Replied, post #43 · Practice › Storage & stability · 30 Dec 2025 · 13 likes The claim about Storing lyophilised material long term upthread is stronger than its source supports. I have read the source. The source says "associated with" and the…
Amylin analogue mechanism: satiety signalling separate from GLP-1 — does this still hold? Replied, post #6 · Compounds › Cagrilintide & amylin analogues · 21 Dec 2025 · 3 likes Everything in post #2 holds. The case it does not cover is the one I have. Historical amylin analogues: pramlintide was the only long-acting amylin analogue licensed…
Research-use-only labelling: what it means and what it does not Replied, post #72 · Sourcing › Regulatory · 13 Dec 2025 · 0 likes I would be cautious about generalising from the research-use-only labelling example above. It is a good example. It is one example.
About the Dosing & titration category Replied, post #3 · Practice › Dosing & titration · 25 Nov 2025 · 12 likes As a member rather than staff: the most useful thing I did when I started reading this category was to work through the tag pages rather than the topic list. The topic…
Revisiting: Why tirzepatide titration schedules have more steps than semaglutide's Replied, post #36 · Compounds › Tirzepatide · 10 Nov 2025 · 0 likes I read post #34 twice before replying, because I had assumed the opposite. Marking my uncertainty on tirzepatide titration schedules explicitly. I am confident about…
Second pass at: Programming during a large energy deficit Replied, post #63 · Nutrition & Training › Resistance training · 1 Nov 2025 · 29 likes Strength and hypertrophy respond to different things, and preserving one during a deficit is a different objective from building the other.
A 40-week log with the measurement method stated Replied, post #56 · Outcomes › Progress reports · 23 Oct 2025 · 3 likes Reframing 40-week log slightly, because I think the disagreement is about the question rather than the answer. If the question is "does it happen", yes. If it is "how…
SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on Replied, post #57 · Compounds › Tirzepatide · 21 Oct 2025 · 13 likes Practical experience of SURMOUNT-4, offered as one case with the conditions stated, not as a general finding. Conditions first, because they are what make it…
Payment mechanics and the recovery options that do not exist Replied, post #31 · Sourcing › Payments · 20 Oct 2025 · 4 likes Building on post #28 rather than restating it. The arithmetic on payment mechanics is the easy part and it is where the errors are, which is an uncomfortable…
Sleep tracking data and its considerable limitations Replied, post #22 · Wellbeing › Sleep · 17 Oct 2025 · 1 like The practical version of sleep is three sentences long. The rigorous version is three pages and reaches the same conclusion with the conditions attached.
Cagrilintide's dosing interval and the pharmacokinetics behind it Replied, post #22 · Compounds › Cagrilintide & amylin analogues · 1 Oct 2025 · 0 likes This is the sort of exchange that makes the archive worth searching.
Second pass at: The mass-error checker and its intended scope Replied, post #28 · Data & Tools › Calculators · 30 Sep 2025 · 33 likes Where I part company with post #24, and it is a narrow parting. The honest answer on mass-error checker is that it depends, and the useful part is the list of what it…
Hypertension improvement and when medication needs revisiting Replied, post #39 · Clinical › Comorbidities · 3 Sep 2025 · 13 likes Hypertension improvement would be much easier to settle if anyone reported the denominator. Almost nobody reports the denominator.
Pinch or no pinch, and how needle length changes the answer Replied, post #27 · Practice › Administration · 20 Aug 2025 · 8 likes Clear enough that I do not think I have a follow-up, which is unusual.
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #85 · Data & Tools › Calculators · 17 Aug 2025 · 0 likes The most common input error is entering the vial mass in the concentration field. It produces a plausible number, which is why it survives.
Coming back to: Sample size calculations, read backwards from the published number Replied, post #72 · Evidence › Trials · 11 Aug 2025 · 23 likes Post #69 is right about the mechanism and I think understates the practical bit. Sample size calculations looks different depending on whether you are reading the…
Follow-up: History of disordered eating and why it changes the conversation Replied, post #58 · Clinical › Special populations · 11 Aug 2025 · 22 likes Building on post #57 rather than restating it. Body weight at the extremes of the studied range affects exposure and the trials rarely reported enough to say by how…
Publishing an inconvenient result: a case study Replied, post #60 · Sourcing › Independent verification · 3 Aug 2025 · 2 likes Post #59 answers the question as asked. The question underneath it is different. My position on publishing an inconvenient result is current rather than settled. I have…
What the GIP component of tirzepatide is thought to contribute, and how confident we can… Replied, post #17 · Compounds › Tirzepatide · 21 Jul 2025 · 9 likes Speaking only to GIP component of tirzepatide as I have actually seen it, rather than as it is usually described: the effect is real, it is smaller than the thread…
A field-by-field walk through a certificate of analysis Replied, post #78 · Analytics › COA interpretation · 16 Jul 2025 · 13 likes Practical experience of field-by-field walk through a certificate, offered as one case with the conditions stated, not as a general finding. Conditions first, because…
A field-by-field walk through a certificate of analysis Replied, post #41 · Analytics › COA interpretation · 15 Jul 2025 · 4 likes Endotoxin testing is separate: a certificate of purity says nothing about endotoxin. A chemically pure preparation can carry a clinically significant endotoxin load. If…
Second pass at: Triple agonism: additive, synergistic, or neither? Replied, post #78 · Compounds › Retatrutide · 12 Jul 2025 · 0 likes The arithmetic in post #75 is right; the assumption feeding it is the part to check. Nausea and vomiting were dose-related in the phase 2 work, as they are throughout…
About the Side effects category Replied, post #5 · Practice › Side effects · 11 Jul 2025 · 8 likes Reported effects on taste and on food preference are common and interesting and unstudied in any detail. They are also the ones people find most disconcerting. The…
Hepatic steatosis: what the MASH trial evidence supports Replied, post #76 · Clinical › Comorbidities · 27 Jun 2025 · 17 likes Post #72 and I disagree about the size of the effect, not about the direction. Nothing here is medical advice and clinicians posting in this subcategory say so on their…
[2026 update] Citation sweep results: how many references did not say what was claimed Replied, post #37 · Meta › Wiki maintenance · 18 Jun 2025 · 0 likes Adding the measurement that post #36 says would settle it. Citation sweep results: I would want to see the raw numbers rather than the summary before agreeing.…
Reading a regulatory notice rather than an article about it — what changed since Replied, post #21 · Sourcing › Regulatory · 16 Jun 2025 · 8 likes Research-use-only material is not approved for human use anywhere. That is a statement about the material's regulatory category rather than about its quality.
Half-life, steady state, and accumulation worked through Replied, post #105 · Pharmacology › Pharmacokinetics · 12 Jun 2025 · 0 likes Confirming post #103 from a second method, which matters more than confirming it from a second person. Terminal half-life estimated from a short sampling window…
Reading a chromatogram someone posted without axes Replied, post #44 · Analytics › HPLC & UHPLC · 11 Jun 2025 · 0 likes Adding the measurement that post #41 says would settle it. Practical answer on reading a chromatogram, since the theoretical one is upthread: do the simplest check…
Coming back to: Getting a referral rather than a refusal Replied, post #35 · Clinical › Prescriber conversations · 5 Jun 2025 · 6 likes On post #31 — agreed on the reasoning, with one qualification. Prescribers reading this subcategory consistently say the most difficult consultations are the ones where…
Reading a trial's population section before its results — does this still hold? Replied, post #72 · Evidence › Trials · 5 May 2025 · 0 likes A trial that answers a slightly different question from the one you have is the normal situation rather than a failure of the trial. The skill is describing the gap…
Anxiety in the first weeks: drug, situation, or both Replied, post #76 · Wellbeing › Mental health · 17 Apr 2025 · 11 likes Taking post #73 at face value and following it one step further. Adding a small correction to the anxiety summary above rather than a disagreement with it. The…
Retatrutide dose escalation in the published trials Replied, post #113 · Compounds › Retatrutide · 10 Apr 2025 · 0 likes Building on post #112 rather than restating it. What we do not know about retatrutide, listed explicitly: long-term safety, real-world response rates, the dose response…
A promotion I argued against, and why I lost Replied, post #143 · Documentation › Doc review · 22 Mar 2025 · 12 likes Worth separating two things that post #141 runs together. Where the review finds the content is right but the framing overstates it, that is the most valuable catch…
What the published dose-response for semaglutide actually looks like above 2.4 mg — a… Replied, post #106 · Compounds › Semaglutide · 18 Mar 2025 · 6 likes The opalescent appearance in semaglutide solutions is occasionally noted and the mechanism is unclear. It does not appear to correlate with product failure in practice.…
Revisiting: Oral versus injected administration claims for BPC-157 Replied, post #3 · Compounds › Repair & healing peptides · 7 Mar 2025 · 3 likes Confirming the opening post from a second method, which matters more than confirming it from a second person. A definition problem is doing most of the work in this…
Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #21 · Evidence › Journal club · 3 Mar 2025 · 30 likes Adding the measurement that post #18 says would settle it. On SURMOUNT-OSA, I would rather understate and be corrected upward than overstate and be quoted. That is a…
Reading a chromatogram someone posted without axes Replied, post #7 · Analytics › HPLC & UHPLC · 1 Mar 2025 · 8 likes Everything in post #3 holds. The case it does not cover is the one I have. Carryover from a previous injection shows up as a small peak at the same retention time in a…
Consistent declarations and why they matter more than clever ones Replied, post #104 · Sourcing › Logistics · 28 Feb 2025 · 23 likes A request rather than an answer: could whoever has the primary source for consistent declarations post it? I have seen the claim three times this month and each version…
Pharmaceutical compounding rules, summarised from primary sources Replied, post #5 · Sourcing › Regulatory · 27 Feb 2025 · 9 likes Everything in post #4 holds. The case it does not cover is the one I have. Since pharmaceutical compounding rules keeps coming up, it should probably be a maintained…
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #139 · Evidence › Journal club · 24 Feb 2025 · 2 likes Grateful for the specificity. Vague answers to this question are what sent me looking.
Second pass at: Gauge and length selection for subcutaneous injection Replied, post #34 · Devices › Syringes & needles · 24 Feb 2025 · 8 likes Post #31 is the version of this I will quote in future. One addition. Sharps containers are a legal requirement for disposal in several jurisdictions and a sensible…
Journal club: SUSTAIN 6 and its retinopathy signal — does this still hold? Replied, post #44 · Evidence › Journal club · 19 Feb 2025 · 24 likes The baseline characteristics table is the single most useful page for the questions that get asked here, because it tells you who the result applies to.
Coming back to: The nausea timeline across the first four weeks, with a tabulated log Replied, post #46 · Practice › Side effects · 31 Jan 2025 · 3 likes Post #42 put the caveat in the right place and I want to underline it. Answering the nausea timeline question as asked, then the question I think is meant. As asked:…
Coming back to: Renal impairment: what the labelling says about dose Replied, post #33 · Clinical › Special populations · 31 Jan 2025 · 7 likes The bit of Renal impairment that nobody enjoys is that the answer changes depending on what you are trying to decide with it. Say what the decision is and the thread…
Canadian access and provincial variation Replied, post #24 · Regional › North America · 27 Jan 2025 · 0 likes Same experience here, different supplier, so it is at least not unique to one of them.
Revisiting: Bug report: the reconstitution calculator and a rounding edge case Replied, post #60 · Data & Tools › Calculators · 21 Jan 2025 · 0 likes This settles it for me, at least until somebody posts a reason it should not.
What changed in 2026, by region Replied, post #73 · Access › International · 12 Jan 2025 · 10 likes Regulatory position dates: a regulatory position is only current as of when it was written. Rechecking is prudent, especially if you saw it months ago. One case, stated…
Oral semaglutide bioavailability and its variability between people — a second dataset Replied, post #119 · Compounds › Oral incretins · 28 Dec 2024 · 6 likes Same experience here, different supplier, so it is at least not unique to one of them.
[2026 update] New subcategory: rationale and scope Replied, post #100 · Meta › Announcements · 28 Dec 2024 · 1 like I had written a reply contradicting post #98 and deleted it. Here is what survived. Last note on this: announcements here get more replies than most topics and almost…
Oral semaglutide bioavailability and its variability between people — a second dataset Replied, post #15 · Compounds › Oral incretins · 25 Dec 2024 · 16 likes Oral semaglutide bioavailability is one of those subjects where the general answer and the answer for a specific case diverge, and the thread will go in circles until…
Building a sensible monitoring schedule with your prescriber Replied, post #107 · Clinical › Bloodwork · 23 Dec 2024 · 0 likes Post #105 is the version of this I will quote in future. One addition. Careful with the language on building a sensible monitoring schedule. "Not detected" and "not…
Semaglutide half-life: where the 165 to 184 hour figure comes from — what changed since Replied, post #66 · Compounds › Semaglutide · 19 Dec 2024 · 17 likes On the injection-day question: the labelling for licensed semaglutide allows the day to be changed provided at least two days separate the two injections. That interval…
Isotonicity and what happens when you get it wrong Replied, post #3 · Pharmacology › Formulation chemistry · 18 Dec 2024 · 21 likes Building on post #2 rather than restating it. Residual moisture in a lyophilised product is a stability determinant and is measured by Karl Fischer titration. Above a…
Second pass at: Gauge and length selection for subcutaneous injection Replied, post #6 · Devices › Syringes & needles · 2 Dec 2024 · 12 likes Reporting rather than recommending, on Gauge and length selection. What happened is above. Whether it should have is a different question and not one I am qualified to…
Coming back to: Cost per delivered dose, which is the number that matters Started this topic · Access › Pricing · 1 Dec 2024 · 11 likes On the subject in the title: Cost per delivered dose, which is the number that matters Working notes rather than a conclusion. Documenting an access outcome, dated,…
When "no data" is the complete and final answer Replied, post #25 · Compounds › Other compounds · 21 Nov 2024 · 12 likes Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature, which puts it in a different evidential category from most of its…
Revisiting: Melanocortin agonists: mechanism and the documented adverse profile Replied, post #114 · Compounds › Other compounds · 13 Nov 2024 · 0 likes The arithmetic on Melanocortin agonists is the easy part and it is where the errors are, which is an uncomfortable combination. Show your working and someone will catch…
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #144 · Clinical › Bloodwork · 26 Oct 2024 · 0 likes Where I part company with post #140, and it is a narrow parting. Time of day: some biomarkers vary across the day. Cortisol in the morning differs from cortisol in the…
Follow-up: Where the four-week escalation interval comes from, and what it is not Replied, post #90 · Practice › Dosing & titration · 25 Oct 2024 · 3 likes Taking post #87 at face value and following it one step further. What I would check first on four-week escalation interval is whether the thing being measured moved or…
Reporting a discrepancy without making an allegation Replied, post #90 · Sourcing › Vendor reports · 24 Sep 2024 · 1 like If the supplier was asked about a discrepancy, include what they said verbatim rather than summarised. The wording of a response is informative.
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #4 · Clinical › Bloodwork · 1 Sep 2024 · 0 likes Picking up post #3: that is the part I would want checked first. Reframing bring a laboratory slightly, because I think the disagreement is about the question rather…
Coming back to: The nausea timeline across the first four weeks, with a tabulated log Replied, post #11 · Practice › Side effects · 30 Aug 2024 · 1 like Pancreatitis: a rare but serious event with a specific presentation (epigastric pain, back pain, elevated lipase). If this constellation of findings appears, stopping…
Second pass at: Retatrutide dose escalation in the published trials Replied, post #94 · Compounds › Retatrutide · 22 Jul 2024 · 2 likes Noted, and thank you for writing it out rather than summarising it.
Oral contraceptives and delayed emptying: what the data shows Replied, post #68 · Practice › Interactions · 18 Jul 2024 · 3 likes Everything in post #64 holds. The case it does not cover is the one I have. Anticoagulant questions come up regularly and are the clearest case for professional advice…
The topic list is dense — is that deliberate? Replied, post #5 · Meta › Site feedback · 16 Jul 2024 · 7 likes The question underneath topic list is usually "how would I tell?" rather than "what is true?", and that one has a method attached to it. Write down what you would…
Cold packs, phase-change material, and what survives ten days Replied, post #83 · Sourcing › Logistics · 8 Jul 2024 · 17 likes The version of cold packs that I was taught turned out to be a teaching simplification. Useful, and not true in the way I had assumed it was.
Assessing a warm arrival: the decision process — one year on Replied, post #43 · Sourcing › Logistics · 30 May 2024 · 2 likes Agreed, and I will stop repeating the version of this I had been repeating.